Has Anne Curtis, MD received payments from drug or device companies?

Yes. Drug and device makers reported $182,166 in general payments to Anne Curtis, MD across 231 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Anne Curtis, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Anne Curtis, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Anne Curtis, MD

Clinical Cardiac Electrophysiology · Buffalo, NYNPI 1245275445

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (55.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 61.9% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $39,552, 2.3 times the $17,517 reported in 2019. Among clinical cardiac electrophysiology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$182,166in general payments, 2019–2025

Across 231 payments — averaging $788.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$113K
Sanofi-aventis U.S. LLC$35K
Abbott$25K
Eagle Pharmaceuticals, Inc.$4K
Janssen Scientific Affairs, LLC$3K
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$2K
plus $170 from 2 others

$37,921in research payments, 2019–2025

Across 25 payments — averaging $1516.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Janssen Scientific Affairs, LLC$15K
Medtronic$14K
Boston Scientific$6K
Sanofi-aventis U.S. LLC$3K

What the payments were for

Consulting fees$57,06431%
Speaking & faculty fees$101,23056%
Travel & lodging$16,3399%
Food & beverage$6,2473%
Education$1,2861%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	142	$112,824
Sanofi-aventis U.S. LLC	10	$35,108
Abbott	65	$24,784
Eagle Pharmaceuticals, Inc.	3	$4,290
Janssen Scientific Affairs, LLC	6	$2,794
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$2,197
Boston Scientific	2	$110
Baxter Healthcare	1	$60

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$182,166 in reported general payments places this provider in the 90th percentile of 214 clinical cardiac electrophysiology providers in New York.

See all clinical cardiac electrophysiology providers in New York →

Medicare billing

Part B allowed, 2024

$10,944

Medicare patients

Services billed

128

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	92	$130,359
JardianceEmpagliflozin	39	$43,213
XareltoRivaroxaban	26	$30,346
EntrestoSacubitril/Valsartan	14	$14,901
Metoprolol Succinate	111	$1,598
Flecainide Acetate	29	$1,076
Valsartan	17	$911
Furosemide	98	$756
Atorvastatin Calcium	56	$652
Rosuvastatin Calcium	27	$542
Verapamil SrVerapamil Hcl	13	$439
Carvedilol	41	$421
Amlodipine Besylate	41	$328
Lisinopril	24	$255
Metoprolol Tartrate	19	$251

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Buffalo

Vivek ReddyNew York$14.9M
Jacob KoruthNew York$3.7M
Srinivas DukkipatiNew York$2.7M
Amir AhmadiNew York$789K
Larry ChinitzNew York$448K
Felix YangBrooklyn$407K
James IpNew York$347K
Stavros MountantonakisManhasset$321K
Jorge RomeroSyracuse$295K
Nicholas SkipitarisNew York$293K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →